Due to the recent achievements of GLP-1s, Goldman Sachs sees significant potential for Eli Lilly And Co (NYSE: LLY), Novo Nordisk A/S (NYSE: NVO), and other companies to venture
B Of A Securities analyst Ebrahim H. Poonawala revised the rating on several Canadian Banks amid a declining rates scenario.
The analyst says the rapid decline in interest rates (5yr yield -120bp since Oct high) lowers the probability of tail risk events posed by a higher for longer scenario.
On Sunday, gene-sequencing company Illumina Inc (NASDAQ: ILMN) agreed to divest cancer diagnostic test maker Grail Inc as the companies battled with the U.S.